Xeris Biopharma Holdings, Inc. XERS Debt-to-assets
Debt-to-assets at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s debt-to-assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s debt-to-assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported debt-to-assets of 0.7× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s debt-to-assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s debt-to-assets decreased by 22.6% year-over-year, from 0.9× to 0.7×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s debt-to-assets?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s debt-to-assets has grown at a 4.2% compound annual growth rate (CAGR), from 0.5× to 0.7×.
- What does debt-to-assets mean?
- Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.